Impact of a Clinical Pathway for Pelvic Fragility Fractures
Impact of Regional Implementation of a Clinical Pathway for ELderly Patients With pelVIc Fragility fraCtures (PELVIC); a Multicenter, Stepped-wedge Randomized Controlled Trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
393 participants
Jan 21, 2024
INTERVENTIONAL
Conditions
Summary
Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.
Eligibility
Inclusion Criteria2
- Pelvic fragility fracture caused by low energetic trauma
- Patients presented at the emergency room or out-patient clinic of a participating hospital
Exclusion Criteria6
- Patients with high suspicion of a pelvic fracture due to a malignant tumor
- Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease)
- Patients who pre-trauma received palliative or terminal care
- Patients who pre-trauma were wheelchair bound or bedridden
- Patients who suffer from complications from previous pelvic ring fixation
- Patients with insufficient comprehension of the Dutch language to be able to carry out the physiotherapy instructions for early mobilization
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Evidence-based and expert-opinion-based clinical pathway regarding the diagnostic and treatment strategy
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06054165